New study

[Nusch]

Does anybody know or has an idea to find out which antihormon medications have been used in this study?

sciencedaily.com/releases/2...

[MoonRocket]

clinicaltrials.gov/study/NC.......

I believe this is the study

[Tall_Allen]

Here's my article about it:

prostatecancer.news/2022/09...

[Nusch in reply to Tall_Allen]

Thx TA. Can you pls check again? They refer to medications which haven’t been used for prostate cancer before:

„The additional drugs were already FDA-approved for other cancers but hadn't been tested in this way with prostate cancer.“

[Tall_Allen in reply to Nusch]

Yes, that is the trial they are talking about. Both abiraterone and apalutamide are approved to newly diagnosed metastatic PCa, but have not been approved for recurrences after prostatectomy.

[Nusch in reply to Tall_Allen]

Understand, many thx TA.

[bluesnjazz]

As I read it, each guy's oncologist chose them, but it likely would have been a combination of the first generation ADT (Leuprolide, Relugolix, bicalutamide) combined with the sort of second generation drugs such as enzalutamide or apalutamide. These types of trials have become very common recently, and my own urologist recommended doing the same for me.